Axa trimmed its stake in shares of Amdocs Limited (NASDAQ:DOX) by 17.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 253,500 shares of the technology company’s stock after selling 53,800 shares during the quarter. Axa’s holdings in Amdocs were worth $16,726,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. Meeder Asset Management Inc. purchased a new position in shares of Amdocs in the second quarter valued at approximately $107,000. Fort L.P. purchased a new position in shares of Amdocs in the second quarter valued at approximately $118,000. Dynamic Technology Lab Private Ltd purchased a new position in shares of Amdocs in the second quarter valued at approximately $205,000. Capital Fund Management S.A. purchased a new position in shares of Amdocs in the second quarter valued at approximately $218,000. Finally, BNP Paribas Arbitrage SA lifted its position in shares of Amdocs by 102.4% in the second quarter. BNP Paribas Arbitrage SA now owns 4,373 shares of the technology company’s stock valued at $289,000 after acquiring an additional 2,212 shares in the last quarter. 90.89% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Amdocs stock opened at $64.68 on Friday. Amdocs Limited has a one year low of $60.50 and a one year high of $71.72. The company has a market cap of $9.31 billion, a P/E ratio of 17.29, a P/E/G ratio of 1.95 and a beta of 0.52.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 18th. Investors of record on Monday, December 31st will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, December 28th. This represents a $1.00 dividend on an annualized basis and a yield of 1.55%. Amdocs’s payout ratio is 26.74%.
DOX has been the topic of several research reports. Citigroup decreased their target price on Amdocs from $79.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, August 2nd. BidaskClub upgraded Amdocs from a “hold” rating to a “buy” rating in a research report on Tuesday, October 23rd. TheStreet downgraded Amdocs from a “b” rating to a “c+” rating in a research report on Friday, November 9th. Robert W. Baird reiterated a “hold” rating and set a $72.00 price objective on shares of Amdocs in a research report on Thursday, August 2nd. Finally, Zacks Investment Research upgraded Amdocs from a “sell” rating to a “hold” rating in a research report on Friday, September 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $72.60.
ILLEGAL ACTIVITY WARNING: This story was reported by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.wkrb13.com/2018/11/24/axa-cuts-stake-in-amdocs-limited-dox.html.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.
Read More: How Short Selling Works
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.